U.S. Stock News

NYSE:DEA
NYSE:DEAOffice REITs

A Look At Easterly Government Properties (DEA) Valuation After Recent Share Price Momentum

Easterly Government Properties (DEA) has drawn attention after recent share price moves, with the stock showing an 11.4% gain over the past month and a 20.8% total return over the past year. See our latest analysis for Easterly Government Properties. The recent 11.4% 1 month share price return, alongside a 20.8% 1 year total shareholder return but weaker 3 and 5 year total shareholder returns, points to momentum building in the near term after a tougher longer run. If this kind of rebound has...
NYSE:CPT
NYSE:CPTResidential REITs

Camden Property Trust (CPT) Q1 FFO Drop Questions Bullish Sun Belt Apartment Narrative

Camden Property Trust (CPT) opened 2026 with Q1 revenue of US$390.0 million, basic EPS of US$0.40 and net income of US$42.4 million, alongside Funds From Operations of US$122.9 million that many investors watch closely for a residential REIT. Over the past several quarters, revenue has moved from US$387.8 million in Q4 2024 to a range between US$393.1 million and US$399.2 million across 2025, while basic EPS has shifted between US$0.36 and US$1.44 over that same period. Taken together with a...
NYSE:WAB
NYSE:WABMachinery

Is It Too Late To Consider Westinghouse Air Brake Technologies (WAB) After A 39% One-Year Gain?

If you are wondering whether Westinghouse Air Brake Technologies at around US$264.95 is still a sensible entry point or if most of the value is already reflected in the price, this article breaks that question down clearly. The stock has delivered a 39.1% return over the last year, with 22.5% year to date, 3.5% over the last 30 days and a 0.8% decline in the last week. This mix can hint at both enthusiasm and shifting views on risk. Recent coverage has focused on the company as a key name in...
NYSE:JLL
NYSE:JLLReal Estate

JLL Record Q1 Highlights AI Gains And Green Growth Opportunities

Jones Lang LaSalle (NYSE:JLL) reported record Q1 results, highlighting the role of its long running investments in AI and data platforms. The company detailed new and existing capital commitments to green and decarbonization initiatives, including a decarbonization fund launched with Shell. Management framed these moves as part of a broader shift in JLL's business model toward technology driven productivity, market share focus, and sustainability led services. For investors watching...
NYSE:RMD
NYSE:RMDMedical Equipment

ResMed (RMD) Margin Strength At 27.5% Tests Bearish Cost And GLP 1 Narratives

ResMed (RMD) has put up another solid quarter, with Q2 2026 revenue at about US$1.4b and basic EPS of US$2.69, while the trailing 12 month figures sit at US$5.4b of revenue and EPS of US$10.16. Over the past six reported quarters, revenue has moved from US$1,224.5m in Q1 2025 to US$1,422.8m in Q2 2026 and basic EPS has shifted from US$2.12 to US$2.69. This gives a clear view of the top line and per share earnings trend across the recent reporting run. With trailing 12 month earnings up 19%...
NasdaqGS:NTCT
NasdaqGS:NTCTCommunications

Assessing NetScout Systems (NTCT) Valuation After Recent Share Price Momentum

Why NetScout Systems Is On Investors’ Radar NetScout Systems (NTCT) has drawn fresh attention after recent share price moves, with the stock posting returns of 5.2% over the past month and 22.2% over the past 3 months. Those gains have arrived alongside a value score of 4 and an indicated intrinsic discount of about 29.9%. This combination is prompting some investors to reassess how the company’s network and cybersecurity business is currently being valued. See our latest analysis for...
NYSE:BVN
NYSE:BVNMetals and Mining

Buenaventura Permits And San Gabriel Ramp Up Reframe Earnings Outlook

Compañía de Minas BuenaventuraA (NYSE:BVN) reported multiple operational and permitting milestones in Q1 2026, including the production ramp up at San Gabriel. The company received key stage 1 operating and water use permits for San Gabriel, while Yumpag and El Brocal secured capacity expansion approvals. Gold production, company wide revenue, and profitability all saw significant gains in the quarter, alongside these project advances. For investors watching NYSE:BVN, these updates come...
NasdaqCM:GRRR
NasdaqCM:GRRRSoftware

Gorilla Technology Group (GRRR) Is Up 17.9% After $2.8 Billion India AI Infrastructure Expansion

In recent days, Gorilla Technology Group Inc. announced a significant expansion of its India AI infrastructure collaboration with Yotta Data Services, supporting the deployment of 20,736 additional B300 GPU cards in a multi-year project valued at about US$2.80 billion, alongside a deeper investment in real-time infrastructure intelligence firm Astrikos.AI. This combination of a very large GPU deployment tied to one of APAC’s largest NVIDIA DGX Cloud clusters and closer Astrikos.AI...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Is It Too Late To Consider Travere Therapeutics (TVTX) After Its Strong Share Price Rally?

Wondering whether Travere Therapeutics at around US$44.12 is still offering value or if the easy gains are already behind it? This article unpacks what the current price really implies. The stock has shown strong share price moves, with returns of 8.9% over 7 days, 40.4% over 30 days, 11.6% year to date, 108.6% over 1 year, 162.6% over 3 years and 120.5% over 5 years. This naturally raises questions about both upside potential and risk. Recent headlines around Travere Therapeutics have...
NYSE:LOW
NYSE:LOWSpecialty Retail

Lowe's Pro Card Expansion Aims To Deepen Contractor Spend And Insights

Synchrony and Lowe's Companies have expanded their partnership with the launch of the MyLowe's Pro Rewards American Express Card. The new co branded card extends purchasing power and rewards for professional customers beyond Lowe's stores to any location where American Express is accepted. The offering targets small to medium business customers within Lowe's Pro segment, with a focus on broader rewards and financing flexibility. Lowe's Companies, NYSE:LOW, is trading at $233.33, with the...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol Myers Squibb (BMY) Margin Strength In Q1 2026 Challenges Bearish Earnings Narratives

Bristol-Myers Squibb (BMY) opened 2026 with Q1 revenue of US$11.5b, basic EPS of US$1.31 and net income of US$2.7b, setting the tone for how investors will judge its recent profitability. The company has seen quarterly revenue move from US$11.2b and basic EPS of US$1.21 in Q1 2025 to US$11.5b and US$1.31 in Q1 2026. Trailing twelve month EPS reached US$3.57, giving a clearer read on earnings power over the last year. With trailing net profit margin at 15% and recent earnings growth of 34.2%...
NYSE:EMN
NYSE:EMNChemicals

Eastman Chemical Q1 2026 Margin Compression Tests Bullish Earnings Growth Narrative

Eastman Chemical Q1 2026 earnings: headline numbers in focus Eastman Chemical (EMN) has opened 2026 with Q1 revenue of US$2.2b and basic EPS of US$0.94, setting the stage for how investors assess the latest move in profitability. Over recent quarters the company has seen revenue move between US$2.0b and US$2.3b, with basic EPS ranging from US$0.41 to US$2.85, while trailing twelve month EPS sits at US$3.49 on revenue of US$8.6b. With the stock at US$77.53 and trailing net margin at 4.6%...